{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:05:03Z","timestamp":1790024703421,"version":"4.0.1"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Metabolic bariatric surgery (MBS) is the most effective treatment for severe obesity, yet patient selection and prioritization remain largely based on body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) thresholds rather than clinical conditions. The Lancet Diabetes and Endocrinology Commission recently proposed distinguishing clinical obesity (adiposity with obesity-related organ dysfunction) from preclinical obesity (excess adiposity with preserved function). The implications of this framework for MBS practice have not been evaluated.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the prevalence of clinical and preclinical obesity among MBS candidates and examine their demographic and clinical profiles, perioperative risk, and long-term prognosis.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective, multicenter, cross-sectional study audited data of adults (aged \u226518 years) undergoing primary MBS (laparoscopic gastric bypass or sleeve gastrectomy) between January 1, 2014, and December 31, 2025, at 4 high-volume tertiary centers in the UK, Spain, France, and Brazil. Patients who underwent revisional procedures or multiple bariatric operations within the same year were excluded.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Classification of obesity as clinical or preclinical using a pragmatic operationalization.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the prevalence of clinical obesity. Secondary outcomes were patterns of organ dysfunction, BMI levels, baseline American Society of Anesthesiologists classification and Charlson Comorbidity Index, estimated 10-year cardiovascular risk (Framingham risk score), and 30-day major postoperative complications (Clavien-Dindo grade \u22653). Comparative analyses between patients with clinical obesity vs those with preclinical obesity were performed only within each individual cohort. No direct statistical comparisons were performed between centers as patient-level data were not shared across cohorts.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among the 2316 patients included, 1709 (73.8%) had clinical obesity (mean [SD] age across cohorts, 45.6 [11.0] to 48.9 [11.7] years; 1149 women [67.2%]) and 607 (26.2%) had preclinical obesity (mean [SD] age across cohorts, 34.7 [10.4] to 40.0 [9.8] years; 486 women [80.1%]). Clinical obesity was the most prevalent category across all centers (from 62.7% in the Brazilian cohort to 79.3% in the UK cohort). Mean (SD) BMI ranged from 40.2 (4.9) (preclinical obesity in the Brazilian cohort) to 48.5 (9.0) (preclinical obesity in the UK cohort), and BMI levels and BMI category distributions (&amp;lt;40, 40-49, \u226550) were similar between clinical and preclinical obesity. Patients with clinical obesity were significantly older compared with those with preclinical obesity (UK cohort: mean [SD], 48.9 [11.7] vs 39.5 [9.7] years; French cohort: mean [SD], 45.6 [11.0] vs 34.7 [10.4] years; Spanish cohort: mean [SD], 47.1 [9.3] vs 40.0 [9.8] years; Brazilian cohort: mean [SD], 48.3 [11.7] vs 40.0 [9.4] years (all\n P<\/jats:italic>\n &amp;lt; .001) and had a higher American Society of Anesthesiologists classification (UK cohort: median [IQR], 3 [2-3] vs 2 [2-3];\n P<\/jats:italic>\n &amp;lt; .001; French cohort: median [IQR], 3 [3-3] vs 2 [2-3];\n P<\/jats:italic>\n &amp;lt; .001; Spanish cohort: median [IQR], 2 [2-3] vs 2 [1-2];\n P<\/jats:italic>\n &amp;lt; .001; Brazilian cohort: median [IQR], 2 [2-2] vs 2 [2-2];\n P<\/jats:italic>\n = .02), as well as higher estimated cardiovascular Framingham risk score (Spanish cohort: median [IQR], 1.31 [0.20-4.34] vs 0.20 [0.20-1.68]; Brazilian cohort: median [IQR], 1.57 [0.20-5.28] vs 0.20 [0.20-0.20]; French cohort: median [IQR], 8.00 [3.00-13.00] vs 2.00 [1.00-4.00]) (all\n P<\/jats:italic>\n &amp;lt; .001) and all-cause mortality risk (Charlson Comorbidity Index score) (UK cohort: median [IQR], 1 [0-2] vs 0 [0-0]; Spanish cohort: median [IQR], 1 [0-1] vs 0; Brazilian cohort: median [IQR], 1 [1-3] vs 1 [0-1]) (all\n P<\/jats:italic>\n &amp;lt; .001). Clinical obesity was associated with increased 30-day major postoperative complications (Clavien-Dindo grade \u22653) compared with preclinical obesity in the French cohort (4.0% vs 1.1%;\n P<\/jats:italic>\n = .04).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This international, multicenter cross-sectional study found that the majority of MBS candidates met criteria for clinical obesity, while a substantial minority were classified as having preclinical obesity. Despite similar BMI distributions, patients with clinical obesity may have a greater disease burden, higher operative risk, and higher estimated cardiovascular risk, supporting its potential value as a clinically meaningful framework for surgical practice.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.28395","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:30:18Z","timestamp":1786462218000},"page":"e2628395","source":"Crossref","is-referenced-by-count":1,"title":["New Obesity Definition and Clinical Obesity Prevalence for Global Metabolic Bariatric Surgery"],"prefix":"10.1001","volume":"9","author":[{"given":"Simone","family":"Cremona","sequence":"first","affiliation":[{"name":"School of Cardiovascular and Metabolic Medicine and Sciences, King\u2019s College London, London, United Kingdom"},{"name":"Esophagogastric and Metabolic Bariatric Surgery Unit, Department of Surgery, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo V.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Center for Obesity and Diabetes, Hospital Alem\u00e3o Oswaldo Cruz, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Pattou","sequence":"additional","affiliation":[{"name":"Department of General and Endocrine Surgery, Lille University Hospital, University of Lille, INSERM, Institut Pasteur Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Casajoana","sequence":"additional","affiliation":[{"name":"Esophagogastric and Metabolic Bariatric Surgery Unit, Department of Surgery, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Sampaio Souza","sequence":"additional","affiliation":[{"name":"Center for Obesity and Diabetes, Hospital Alem\u00e3o Oswaldo Cruz, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Raverdy","sequence":"additional","affiliation":[{"name":"Department of General and Endocrine Surgery, Lille University Hospital, University of Lille, INSERM, Institut Pasteur Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Verkindt","sequence":"additional","affiliation":[{"name":"Department of General and Endocrine Surgery, Lille University Hospital, University of Lille, INSERM, Institut Pasteur Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz T. L.","family":"Blasio","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cascais Hospital, Cascais, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Roser","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Medicine and Sciences, King\u2019s College London, London, United Kingdom"},{"name":"Department of Endocrinology and Diabetes, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Caiazzo","sequence":"additional","affiliation":[{"name":"Department of General and Endocrine Surgery, Lille University Hospital, University of Lille, INSERM, Institut Pasteur Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Benaiges","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarissa B.","family":"Zanata Petry","sequence":"additional","affiliation":[{"name":"Center for Obesity and Diabetes, Hospital Alem\u00e3o Oswaldo Cruz, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rubino","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Medicine and Sciences, King\u2019s College London, London, United Kingdom"},{"name":"Bariatric and Metabolic Surgery, Department of Upper Gastrointestinal Surgery, King\u2019s College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"13","key":"zoi260773r1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity.","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi260773r2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2014.16968","article-title":"Association between bariatric surgery and long-term survival.","volume":"313","author":"Arterburn","year":"2015","journal-title":"JAMA"},{"issue":"10271","key":"zoi260773r3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"zoi260773r4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes.","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi260773r5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery.","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg Obes Relat Dis"},{"issue":"15","key":"zoi260773r7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi260773r8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity.","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"zoi260773r9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity.","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"zoi260773r10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"zoi260773r11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00000542-196301000-00017","article-title":"New classification of physical status.","volume":"24","author":"Dripps","year":"1963","journal-title":"Anesthesiology"},{"issue":"3","key":"zoi260773r12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00000542-194105000-00004","article-title":"Grading of patients for surgical procedures.","volume":"2","author":"Saklad","year":"1941","journal-title":"Anesthesiology"},{"issue":"5","key":"zoi260773r13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"18","key":"zoi260773r14","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories.","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"zoi260773r15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"zoi260773r16","doi-asserted-by":"publisher","first-page":"q1645","DOI":"10.1136\/bmj.q1645","article-title":"GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment.","volume":"386","author":"Mahase","year":"2024","journal-title":"BMJ"},{"issue":"10","key":"zoi260773r17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.40890","article-title":"Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity.","volume":"8","author":"Li","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi260773r18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S2213-8587(25)00159-7","article-title":"Prevalence of clinical obesity versus BMI-defined obesity among US adults: a cohort study.","volume":"13","author":"Yao","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"zoi260773r19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4093\/dmj.2025.0697","article-title":"Clinical and preclinical obesity in Korean adults from 2014 to 2023.","volume":"50","author":"Choe","year":"2026","journal-title":"Diabetes Metab J"},{"issue":"9","key":"zoi260773r20","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/jcm13092538","article-title":"Obstructive sleep apnea and risk of postoperative complications after non-cardiac surgery.","volume":"13","author":"Chaudhry","year":"2024","journal-title":"J Clin Med"},{"key":"zoi260773r6","unstructured":"Overweight and obesity management. National Institute for Health and Care Excellence. January 14, 2025. Accessed February 17, 2026. https:\/\/www.nice.org.uk\/guidance\/ng246"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852615\/cremona_2026_oi_260773_1785786136.96036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:30:20Z","timestamp":1786462220000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.28395","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}